Vivoo Unveils Revolutionary At-Home UTI Test at CES 2024
Vivoo, the wellness app, has debuted its latest innovation at CES 2024 – a smart urinary tract infection (UTI) test that can be performed at home. Powered by Vivoo’s cutting-edge deep learning image processing technology, the at-home test provides customers with accurate results in just seconds.
The new UTI test promises to revolutionize the way customers manage suspected UTIs. With results available in a matter of seconds and the testing process taking only two minutes, the convenience and speed of the new test are unparalleled. Additionally, the test digitizes data, making it easier for consumers to communicate with their healthcare providers.
Utilizing a user-friendly app, customers can simply urinate onto a strip and use the app to scan and analyze the test results. The deep learning image processing technology ensures gold-standard accuracy, eliminating any confusion in readings.
Miray Tayfun, co-founder and CEO of Vivoo, expressed excitement about the product’s potential to transform UTI diagnosis with convenient at-home testing, facilitated by the user-friendly mobile app. Tayfun emphasized Vivoo’s commitment to democratizing healthcare and ensuring global accessibility through innovative technology.
Notably, the digitalized data allows customers to easily share their results with healthcare providers via the app, streamlining the process of obtaining a prescription if necessary. Furthermore, the app provides access to educational content following the test results.
Vivoo’s new UTI test has already garnered recognition as a CES 2024 Innovation Awards honoree. This recent breakthrough follows the company’s previous success at CES 2023 with the launch of its smart toilet, designed for early health condition detection. Attendees at the Las Vegas show will have the opportunity to explore Vivoo’s latest patient health monitoring technology for smartphones, further solidifying the company’s position as a leader in innovative healthcare solutions.
